本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Biofrontera Inc

0.8539
+0.03624.43%
盘后0.85390.00000.00%16:00 EST
成交量:5.14万
成交额:4.41万
市值:910.97万
市盈率:-0.41
高:0.8999
开:0.8300
低:0.8200
收:0.8177
52周最高:1.87
52周最低:0.5360
股本:1,066.84万
流通股本:795.22万
量比:0.26
换手率:0.65%
股息:- -
股息率:- -
每股收益(TTM):-2.1025
每股收益(LYR):-3.2193
净资产收益率:-531.54%
总资产收益率:-48.85%
市净率:-1.95
市盈率(LYR):-0.27

数据加载中...

2024/03/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/20

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/20

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/15

重要事件披露

Form 8-K - Current report
2024/03/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/02/23

重要事件披露

Form 8-K - Current report
2024/02/20

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/13

重要事件披露

Form 8-K - Current report
2024/02/05

重要事件披露

Form 8-K - Current report
2024/02/02

重要事件披露

Form 8-K - Current report
2024/01/29

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/01/25

重要事件披露

Form 8-K - Current report
2024/01/17

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/01/11

重要事件披露

Form 8-K - Current report
2024/01/09

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/01/03

重要事件披露

Form 8-K - Current report